Why measles spreads so fast, and the immune damage it leaves behind
It hangs in the air for up to two hours and infects the great majority of susceptible people it reaches. Less well known: it can erase part of the immune memory a person had already built to other diseases.
Measles is often described as the most contagious human infection, and the description is close enough to true that it is worth understanding why. The reason is not that the virus is unusually aggressive once it takes hold — measles is dangerous, but many viruses are — but that it is extraordinarily good at getting from one person to the next. Two features do most of that work, and a third, less familiar effect explains why measles casts a shadow long after the rash fades.
An airborne virus that lingers
Most respiratory viruses spread mainly through relatively short-range droplets and need fairly close contact. Measles behaves differently. According to the World Health Organization, the virus spreads through the air and can remain infectious in the air, or on surfaces, for up to two hours after an infected person has left a space [s1]. That single fact changes the arithmetic of an outbreak: a susceptible person can be infected by simply entering a room that a contagious person has already left. The WHO puts the consequence bluntly — measles is so contagious that around 9 in 10 people who are not immune will become infected if they are exposed to someone who has it [s1]. Very few pathogens infect that high a proportion of the people they reach.
The infectiousness is also front-loaded in a way that defeats containment. A person with measles is contagious for several days before the tell-tale rash appears [s1], so they are spreading the virus while they and everyone around them still think they have an ordinary cold. By the time the diagnosis is obvious, exposure has already happened.
What the reproduction number does and does not tell you
The standard shorthand for contagiousness is the basic reproduction number, R0, and measles is routinely quoted at 12 to 18 — meaning one case would, in a fully susceptible population, generate 12 to 18 more. That range is useful as a signal that measles sits at the extreme end of the scale, but a 2017 systematic review in The Lancet Infectious Diseases found it should be handled with care: the familiar 12-to-18 figure traces back to a small number of older studies, and the estimates actually published in the literature vary far more widely [s2]. The review's message is not that measles is less contagious than believed but that R0 is not a fixed property of the virus — it depends on how densely and how often people mix, so it is higher in a crowded, under-vaccinated setting than in a sparse or well-protected one [s2]. The takeaway is directional: measles is at the top of the contagiousness ranking, and the precise number depends on the population.
The part people miss: immune amnesia
The most striking recent finding about measles has nothing to do with how fast it spreads and everything to do with what it leaves behind. A 2019 study in Science found that measles infection can wipe out a portion of the antibodies a person had already accumulated against other pathogens. Measuring the antibody repertoires of unvaccinated children before and after natural measles, the researchers found the infection eliminated a substantial fraction — in their cohort, between about 11% and 73% of the antibody repertoire, depending on the child [s3]. In effect, measles can partially erase the immune system's hard-won memory of infections and vaccinations the person had encountered before, leaving them more vulnerable to diseases they were previously protected against [s3].
This phenomenon, sometimes called immune amnesia, reframes what a measles case costs. It is not only the acute illness — with its risks of pneumonia, brain inflammation and death — but a lasting dent in protection against everything else, one that has to be rebuilt over time [s3]. It also helps explain a longstanding epidemiological observation that measles outbreaks are sometimes followed by increased deaths from other infections. The measles vaccine, by preventing the infection, prevents this collateral immune damage as well [s3].
Why this all points the same way
The features fit together into a coherent picture. An airborne virus that lingers, that infects around nine of every ten susceptible people it reaches, and that is contagious before it is recognisable is one that finds every gap in a population's immunity [s1]. That it also degrades existing immunity to other diseases raises the stakes of each case beyond the illness itself [s3]. Both facts are arguments for keeping susceptibility low in the first place, because measles is a disease that punishes gaps efficiently and remembers them longer than the patient does. This explainer describes the biology of how measles spreads and what it does; it is not clinical guidance for any individual case.
Sources
- Measles — World Health Organization , November 14, 2024
- The basic reproduction number (R0) of measles: a systematic review — The Lancet Infectious Diseases , December 1, 2017
- Measles virus infection diminishes preexisting antibodies that offer protection from other pathogens — Science , November 1, 2019
More on
What herd immunity is, and why each disease needs a different threshold
The more contagious a disease, the more of a population must be immune to stop it spreading. Measles sets the bar near 95%. It is not one figure but a range that depends on where you are.
Lebanon investigated only 52% of suspected measles cases adequately, a review finds
An analysis of a decade of surveillance data shows the system leans heavily on hospitals and misses cases in the community — the weakness that lets measles circulate undetected between outbreaks.
The US is likely to lose its measles elimination status this fall. What that means.
A ruling comes in November. The country has held the status since 2000, and 2026 has already produced more cases than any year in three decades.
The US matched last year's entire measles case count — with six months of 2026 still to go
CDC data through July 2 puts 2026 at 2,170 confirmed cases, just short of all of 2025's 2,289. Ninety-three percent of this year's cases are linked to active outbreaks.